Dry Eye Disease is a condition that affects the surface of the eye and is characterized
by an imbalance in the tear film. Those who suffer from the disease usually deal
with symptoms such as irritation, changes in sight, and inflammation. This review
inspects diagnostic and treatment techniques currently in use. It is based on recent
clinical findings and technological developments. Tools such as dry eye
questionnaires simplify symptom quantification, while Schirmer testing, tear breakup
time, and surface staining remain the main objective measures. Present-day
treatments range from favored artificial tears and topical anti-inflammatory
medicaments (e.g., cyclosporine, lifitegrast) to novel secretagogues (e.g., varenicline
nasal spray, diquafosol), lipid-enhancing agents (e.g., perfluorohexyloctane), and
biologic therapies (e.g., autologous serum). Adjunct procedures like thermal
pulsation, intense pulsed light, and punctal occlusion have often worked well in
stubborn cases. Further, emerging modalities, such as neurostimulatory and nervetargeted
treatments, offer potential for managing neuropathic components of dry
eye disease.
Keywords: dry eye disease, ocular surface, tear film instability, meibomian gland
dysfunction
